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Background. Congenital heart block is characterized by blockage of electrical impulses from the atrioventricular node (AV node)
to the ventricles. This blockage can be caused by ion channel impairment that is the result of genetic variation. This study aimed to
investigate the possible causative variants in a Thai family with complete heart block by using whole exome sequencing.Methods.
Genomic DNAwas collected from a family consisting of five family members in three generations in which one of three children in
generation III had complete heart block. Whole exome sequencing was performed on one complete heart block affected child and
one unaffected sibling. Bioinformatics was used to identify annotated and filtered variants. Candidate variants were validated and
the segregation analysis of other family members was performed. Results. This study identified compound heterozygous variants,
c.101G>A and c.3832G>A, in the SCN5A gene and c.28730C>T in the TTN gene. Conclusions. Compound heterozygous variants in
the SCN5A gene were found in the complete heart block affected child but these two variants were found only in the this affected
sibling and were not found in other unaffected family members. Hence, these variants in the SCN5A gene were the most possible
disease-causing variants in this family.
1. Introduction
Congenital heart block is an uncommon disorder that occurs
in about 1 in 20,000 live births [1]. It is characterized by
anatomical or functional impairment in the conduction
system which is caused by blockage of electrical impulses
from atrioventricular node (AV node) to the ventricles [2].
The severity of heart block ranges from first-degree in which
electrical impulse to the AV node is slower than normal
to third-degree or complete heart block in which electrical
impulses from the atrium do not reach ventricles at all [3].
The conduction defect can be caused by a defective
link between cardiomyocytes or by ion channel impairment
that changes action potential shapes [4]. Inherited defects
in cardiac conduction have been linked to genetic variants
in several genes such as SCN5A, SCN1B, KCNJ2, HCN4,
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Figure 1: Electrocardiography of index case (III-2) shows third-degree atrioventricular block, atrial rate 100/min, ventricular rate 49/min,
and ventricular pacing spikes before some QRS complexes.
NKX2-5, TBX5, LMNA, and ANKB [4–9]. Among these
genes, SCN5A has been frequently reported with various
phenotypes [10]. SCN5A encodes 𝛼 subunit of the cardiac
sodium channel (NaV1.5) which controls the flow of sodium
ions into cells that is essential in generation and transmission
of electrical impulses [11]. A nonfunctional protein, which is
caused by a mutation in the SCN5A gene, reduces entrance of
sodium into the cells that results in difficulty producing and
transmitting electrical signals resulting in heart block [12].
Mutations in SCN5A, which lead to loss or gain of sodium
channel function, are associated with a spectrum of cardiac
diseases including Brugada syndrome, Long QT syndrome
type 3, sick sinus syndrome, and progressive familial heart
block [12–16].
With the advantages of next-generation sequencing espe-
cially whole exome sequencing that can explore the sequence
of all exons in a single experiment, sequencing has been used
in several studies for comprehensive and unbiased identi-
fication of causative variants of diseases in the last decade
[17, 18]. Likewise, whole exome sequencing has been used
in other cardiovascular related studies to identify disease-
causing mutations of familial atrial septal defects [19].
This study aims to investigate the possible causative
variants in a Thai family with complete heart block by using
whole exome sequencing. A combined method of familial
data, exome sequencing, bioinformatics, and segregation
analysis was able to identify 6 variants in 5 genes in which
2 variants in SCN5A were the most plausible disease-causing
variants for heart block.
2. Materials and Methods
2.1. Subjects. The family in this study had 3 generations from
which blood samples for DNA preparations were collected:
grandmother (I-2),mother (II-2), and two children (III-2 and
III-3). The II-2 was a single mother; therefore, we could not
obtain blood for DNA from the father. The index case (III-
2) had a third-degree AV block and had undergone cardiac
surgery for epicardial pacemaker implantation at the age
of 18 months. She was diagnosed with autism according to
the DSM-IV at the age of 6 years. The other two siblings
had no heart defects but one had learning disability (III-
1, no DNA) and the other was autistic (III-3) (Figure 1).
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Extracted DNA samples from III-2 and III-3 were controlled
for their quality by measuring DNA concentration using
Nanodrop ND1000 andmeasuring fragmentation of DNA by
agarose gel electrophoresis. These 2 samples were prepared
for whole exome sequencing. DNA samples from other
family members (I-2, II-2) were prepared for segregation
analysis. Written informed consent was obtained from adult
family members themselves and for all children and all
procedures were approved by the Institutional Review Board
(MURA2012/02/SN1) of the Faculty of Medicine Ramathi-
bodi Hospital, Mahidol University, and EC48/364-006-3 of
the Faculty of Medicine, Prince of Songkla University.
2.2. Exome Sequencing and Data Analysis. Whole exome se-
quencing was performed on family members III-2 and
III-3. Samples were prepared following standard SOLID
5500xl (Applied Biosystems, California, USA) protocols for
whole exome sequencing. Three micrograms of genomic
DNA of each sample were fragmented using Covaris S2
(Covaris, Massachusetts, USA) and were captured for exome
sequencing using TargetSeq Exome and Custom Enrichment
System (Invitrogen, California, USA). The captured DNA
was sequenced with 150 bp paired-end read on the SOLID
5500xl system according to the manufacturer’s protocol.
Primary analysis was performed on the sequencing machine
using SOLID ICS software; then, raw sequenced data was
transferred to the LifeScope Genomic Analysis server for
secondary analysis. Sequence reads were mapped to the
human reference genome assembly hg19 (GRCh37); then,
variants calling for SNV, insertions, and deletions were
performed.
Tertiary analysis was performed by using Golden Helix
SVS software on identified candidate variants. Variants were
filtered for minimum genotype quality of 20 and minimum
coverage depths of 10 and then the qualified variants were
annotated with the UCSC KnownGenes database to remove
noncoding and synonymous variants. High frequency vari-
ants (minor allele frequencies greater than 2%)were excluded
by annotation with allele frequencies from the 1000 Genomes
Project Phase 3 [20] and an in-house exome database which
consists of 172 Thai individuals. Deleterious protein func-
tions were predicted using dbNSFP that compiled prediction
scores from eleven prediction algorithms (SIFT, Polyphen2,
LRT, MutationTaster, MutationAssessor, FATHMM, VEST3,
CADD, MetaLR, MetaSVM, and PROVEAN) and 4 con-
servation scores, PhyloP, phastCons, GERP++, and SiPhy,
and other related information [21]. Variants that were pre-
dicted not to alter protein function by any algorithm were
excluded in this step. To narrow down variants, variants were
focused on where these were located in the candidate genes
list (Table 1). This genes list was created from combined
known and suspected genes involved in the cardiovascu-
lar system from several sources and the cardiovascular
defective candidate genes from the Enlis Genome Research
software (Enlis, Berkeley, CA) gene panel. This genes list
consists of 359 genes in total. Lastly, variants were filtered
by their genotype. A genotype that was only in family
member III-2 was indicated as a candidate variant for heart
block. The summarized variants filter steps are shown in
Figure 3.
Additionally, pathogenic variants which were related to
other diseases followed were explored in The American
College of Medical Genetics and Genomics (ACMG) recom-
mendations for reporting of incidental findings in clinical
exome and genome sequencing [22]. Known pathogenic
variants were identified by usingThe Human Gene Mutation
Database (HGMD) [23].
2.3. Variant Validations and Segregation Analysis. Sanger se-
quencing was used to validate the candidate variants found in
whole exome sequencing and segregation analyses were per-
formed on the family members. Primers were designed using
the Primer3 version 0.4.0 web-based tool [24]. Sequencing
reactions were performed using Applied Biosystems 3130
DNA Analyzer (Life Technologies, Carlsbad, CA, USA).
3. Results
A family with complete heart block in only one of the 3rd
generation family members was explored. By whole exome
sequencing, a total of 99,834 variants in familymembers III-2
and III-3 were detected with an average depth over 60x cover-
age.After removal of lowquality, noncoding and synonymous
variants, 14,284 variants remained. Subsequently, variants
were reduced by a filtering pipeline that included variants
with minor allele frequencies, inheritance models, and a
candidate gene list which reduced the number of variants to
36 variants in 28 genes. Finally, variants were prioritized and
selected as candidate variants by annotated information from
the deleterious protein function prediction database that
resulted in 21 heart defective candidate variants in 18 genes. A
list of candidate variants is shown in Table 2. All 21 candidate
variants were then investigated for validation and segregation
analysis. Six variants successfully passed this step while the
other variants were dropped for 2 reasons: (1) a discordance
between whole exome sequencing and Sanger sequencing or
(2) variants found in the affected child being found in other
unaffected family members except for two or more variants
that were found in the same gene which indicated compound
heterozygous inheritance. These 6 variants in 5 genes were
identified as candidate variants for heart defects in this family.
The list of final candidate variants is shown in Table 3.
Two nonsynonymous missense variants in the SCN5A
gene in this study, c.101G>A and c.3832G>A (NM 000335),
were likely to be present in a compound heterozygous fashion
because 2 heterozygous variants were found in same gene in
the affected case but only one or none of them were found
in unaffected family members. Heterozygous c.101G>A was
found in III-2 (index) and II-2 (mother) while heterozygous
c.3832G>A was found in III-2 (index) and III-3 (brother)
(Figure 2). Chromatograms of both variants in all available
subjects are shown in Figure 4.
All other 4 variants were nonsynonymous missense
variants in which their genotypes were heterozygous. These
variants consisted of c.28730C>T (NM 133378) in the


















Figure 2:The lineage of the familywith complete heart block indicated by the dark symbol, females by circles, andmales by squares. Letters (a)
and (b) indicate genotypes of 2 variants in the SCN5A gene for c.101G>A and c.3832G>A.The homozygous reference genotypes are indicated
by (−/−) and heterozygous alternate genotypes by (−/+). The genotypes of II-1 are presumed genotypes which are inferred from his children.
Total variants from 2nd analysis
99,834 variants
















Figure 3: Filtering procedure of variants obtained by whole exome sequencing 2nd data analysis.
c.1133A>T (NM 012144) in the DNAI1 gene, and c.13481A>C
(NM 002458) in the MUC5B gene. TTN encoded Titin
or connectin, a giant muscle protein, is expressed in the
cardiac and skeletal muscles. NPHP3 encodes a protein that
is required for normal ciliary development. DNAI1 encodes
a member of the dynein intermediate chain family. Lastly,
MUC5B encodes a protein member of the mucin family.
Finally, incidental findings in the whole exome data
in this family following ACMG recommendations were
explored. Aside from variants in the SCN5A gene that were
assigned in the ACMG panel as known/expected pathogenic
variants for Romano-Ward Long QT syndromes Types 1, 2,
and 3 and Brugada syndrome, which were key variants in this
family, a variant in theMYBPC3 gene that was assigned in the
ACMG panel for hypertrophic/dilated cardiomyopathy was
explored and validated.
4. Discussion
Although a congenital heart defect was found in this autistic
patient, this was unlike the Timothy syndromewhich is a rare
disorder that affects heart, nervous system, and fingers/toes.
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(a) SCN5A c.101G>A [C>T]
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AAAC YG G GTTT
C/T








(b) SCN5A c.3832G>A [C>T]
Figure 4: Chromatograms of 2 heterozygous missense variants in SCN5A gene: c.101G>A (a) and c.3832G>A (b). Letters in [] indicate
complementary (FWD) alleles.
Syndactyly, the webbing of fingers and toes, one of Timothy
syndrome signs, was not found in this case. Moreover, by
direct sequencing and whole exome sequencing, variants in
the CACNA1C gene, which are the common causes of both
classical and atypical Timothy syndrome, were not detected
[25]. Therefore, it was inferred that heart block and autism in
this family are a coincidence.
SCN5A, a cardiac sodium channel gene, is important in
generation and transmission of electrical impulses by its role
in controlling the flow of sodium ions into cells [11]. Several
variants in the SCN5A that are located in four homologous
domains of alpha subunit of NaV1.5, including 6 segments
of each domain and linkers, N-terminal, and C-terminal,
have been reported to be associated with various phenotypes
of cardiac diseases [26]. The mechanism of SCN5A muta-
tions associated with cardiac conduction disease has been
explained by loss of function in NaV1.5 channels. Loss of
NaV1.5 function leads to a reduction of inward sodiumflow in
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Table 1: List of genes involved in cardiovascular system defects.
AARS2 ATP6V0A2 CSRP3 FASTKD2 HAND1 LMF1 MYH11 PLN SFTPA1 TGFB2
ABCA1 ATRX CTF1 FBLN5 HAND2 LMNA MYH6 PLOD1 SFTPA2 TGFB3
ABCA3 B3GAT3 CTNNA3 FBN1 HCN4 LPIN1 MYH7 PNPLA3 SFTPB TGFBR1
ABCC6 BAG3 DES FBN2 HERG LPL MYL2 PPARA SFTPC TGFBR2
ABCC9 BCOR DHCR24 FGD1 HFE LRP5 MYL3 PPARG SFTPD THEMIS
ABCG5 BMPR2 DHCR7 FGFR2 HOXA1 LTBP4 MYLK PPP1R17 SGCD TLL1
ABCG8 BRAF DLL3 FHL1 HRAS MAP2K1 MYLK2 PRDM16 SGCG TMEM43
ACADVL CACNA1B DMD FHL2 IGBP1 MAP2K2 MYO6 PRKAB2 SHOC2 TMEM70
ACTA1 CACNA1C DMPK FKTN ILK MED12 MYOCD PRKAG2 SKI TMPO
ACTA2 CACNA1D DNAH11 FLNA IRX4 MEF2C MYOM1 PRKAR1A SLC25A3 TNNC1
ACTC CACNA2D1 DNAH5 FLNB JAG1 MHY11 MYOT PRKG1 SLC25A4 TNNI3
ACTC1 CACNB2 DNAI1 FOXC2 JPH2 MIB1 MYOZ2 PSEN1 SLC2A10 TNNT2
ACTN2 CALM1 DNAJC19 FOXH1 JUP MID1 MYPN PSEN2 SLMAP TNXB
ACVR2B CALM2 DNM1L FOXRED1 KCNA5 MKKS NEBL PTPN11 SMAD3 TOPBP1
ACVRL1 CALR3 DOLK FRYL KCND3 MKS1 NEXN PTRF SMAD4 TPM1
ADCK3 CASQ2 DPP6 FXN KCNE1 MOG1 NF1 RAF1 SMAD9 TPM2
ADRB1 CAV1 DSC2 GAA KCNE1L MRPL3 NIPBL RAI1 SNTA1 TRDN
AGL CAV3 DSG2 GATA4 KCNE2 MTND1 NKX2.5 RANGRF SNX3 TRIM63
AKAP9 CBL DSP GATA5 KCNE3 MTND5 NKX2.6 RASA1 SOS1 TRPM4
AKT3 CBS DTNA GATA6 KCNH2 MTND6 NKX2-5 RBM10 SOX2 TSFM
ALMS1 CFC1 EFEMP2 GATAD1 KCNJ2 MTTD NODAL RBM20 SOX7 TTN
ALPK3 CHD7 EIF2AK4 GATT6 KCNJ5 MTTG NOS1AP RET SPEG TTR
ANGPTL3 CHST14 ELMOD2 GDF1 KCNJ8 MTTH NOTCH1 RPL4 SPRED1 TWIST1
ANGPTL4 COA5 ELN GDF2 KCNK3 MTTI NOTCH2 RPSA SURF1 TXNRD2
ANK2 COL18A1 EMD GJA1 KCNQ1 MTTK NOTCH3 RYR1 SYNE1 UQCRB
ANKRD1 COL1A1 ENG GJA5 KRAS MTTL1 NPC1 RYR2 SYNE2 USF1
ANO5 COL1A2 EPHX2 GLA LAMA4 MTTL2 NPHP3 SALL1 TAZ VCL
APOA1 COL2A1 ESCO2 GLB1 LAMP2 MTTM NPPA SALL4 TBX1 VCP
APOA2 COL3A1 EVC GLI3 LBR MTTP NRAS SCN1B TBX20 VHL
APOA5 COL4A1 EVC2 GNAI2 LCAT MTTQ NSDHL SCN2B TBX3 XK
APOB COL5A1 EYA1 GPC3 LDB3 MTTS1 NUBPL SCN3B TBX5 ZASP
APOC2 COL5A2 EYA4 GPD1L LDLR MTTS2 PCSK9 SCN4B TCAP ZFPM2
APOE CREBBP FANCA GPIHBP1 LDLRAP1 MUC5B PDLIM3 SCN5A TCTN3 ZIC3
ARHGAP31 CRELD1 FANCC GSN LEFTY2 MYBPC3 PEX7 SCO2 TERC ZMPSTE24
ARX CRYAB FANCD2 GUSB LIPC MYCN PKP2 SDHA TERT ZNF469
ATP5E CSF2RA FANCE HADH LIPI MYF6 PKP4 SEMA5A TFAP2B
the cells that results in difficulty producing and transmitting
electrical signals. Conduction defects, however, could occur
apart from transmission of inward sodium. The mutations
on SCN5A, p.R219H, p.R222Q, and p.R225W which express
alternative pathways, through a cation leak through NaV1.5,
have been reported to be associated with mixed arrhythmias
and dilated cardiomyopathy [27, 28]. In this study, 2missense
variants in the SCN5A gene in a patient who had complete
heart block (III-2)were identified.Thefirst variant, c.101G>A,
results in replacement of arginine by histidine (p.R34H) in
exon 2 whereas the second variant, c.3832G>A, results in
replacement of valine by isoleucine (p.V1278I) in exon 21.
Both variants were rare variants in which alternate alleles
were not found in the Asian population from 1000 genome
databases and the Thai population from the Thai in-house
exome database. Functional prediction results show that
both variants were predicted to alter protein function which
indicates that these variants have a high possibility to damage
function of the sodium channel and cause the conduction
defect in this case (Table 3).
c.101G>A (p.R34H) is a novel variant which is located
in the N-terminal cytoplasmic domain of the sodium chan-
nel alpha subunit (Figure 5). A variant (c.80G>A) in the
same region, the N-terminal cytoplasmic domain of sodium
channel, has been reported to be associated with Brugada
syndrome by Priori et al. [29]. Makita et al. have reported a
mutation, which resulted in a stop codon (p.Q55X), presented
in a Brugada syndrome affected patient with 1st-degree AV
block history [30].
c.3832G>A (p.V1278I) has been reported as a “dis-
ease causing mutation” of dilated cardiomyopathy in the
HGMD database [31–33]. This variant is located in the S3
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Table 2: Candidate variants from whole exome sequencing.
Position Gene Classification Transcript HGVS coding dbSNP
Chr1: 13036736 PRAMEF22 Nonsyn SNV NM 001100631 c.808T>A rs202011965
Chr2: 179402104 TTN Nonsyn SNV NM 003319 c.72635G>A —
Chr2: 179542464 TTN Nonsyn SNV NM 133378 c.30443C>T —
Chr2: 179549988 TTN Nonsyn SNV NM 133378 c.28730C>T rs146400809
Chr2: 203395591 BMPR2 Nonsyn SNV NM 001204 c.1042G>A rs201067849
Chr3: 38607905 SCN5A Nonsyn SNV NM 000335 c.3832G>A rs199473341
Chr3: 38674698 SCN5A Nonsyn SNV NM 000335 c.101G>A rs199473046
Chr3: 132438619 NPHP3 Nonsyn SNV NM 153240 c.449C>T rs142663818
Chr7: 42064927 GLI3 Nonsyn SNV NM 000168 c.1292A>G —
Chr9: 34506694 DNAI1 Nonsyn SNV NM 012144 c.1133A>T —
Chr9: 97080945 FAM22F Del NM 017561 c.2071 2073delTCT rs150455117
Chr11: 1267969 MUC5B Nonsyn SNV NM 002458 c.9859A>C —
Chr11: 1271591 MUC5B Nonsyn SNV NM 002458 c.13481A>C rs201038498
Chr11: 47356616 MYBPC3 Unknown NM 000256 c.2883C>T —
Chr11: 126143258 FOXRED1 Frameshift Del NM 017547 c.445delC —
Chr12: 58177067 TSFM Splicing NM 001172695 c.231+1 231+2delGT —
Chr12: 112892433 PTPN11 Stop-gain NM 002834 c.591T>G rs76982592
Chr16: 1245007 CACNA1H Nonsyn SNV NM 001005407 c.335T>C —
Chr16: 71061495 HYDIN Stop-loss NM 017558 c.3052T>C rs146649547
Chr16: 89815152 FANCA Nonsyn SNV NM 000135 c.3263C>T rs17233497
Chr21: 35821734 KCNE1 Nonsyn SNV NM 001127670 c.199C>T rs199473645
NH2 COOH
DI DII DIII DIV
R34H
V1278I
Figure 5: Schematic of the transmembrane topology of the SCN5A protein. The location of the variants R34H (c.101G>A) and V1278I
(c.3832G>A) is shown.
transmembrane segment of domain III (DIII) of the sodium
channel alpha subunit. McNair et al. have reported that
heterozygous c.3823G>A variant, which is located near
c.3832G>A, was associated with dilated conduction disorder,
cardiomyopathy, and arrhythmia [34]. In the same region, an
association between atrial standstill and p.D1275Nwith poly-
morphisms in other gap junction protein, connexin40, has
been reported by Groenewegen et al. [35]. Electrophysiolog-
ical studies in xenopus oocytes showed that the c.3823G>A
mutation results in an activation curve shift of the sodium
channel conductance [35]. This activation curve shift toward
more positive voltages may result in reduced excitability of
myocytes. According to studies of Gosselin-Badaroudine et
al. and Moreau et al., this electrical disturbance could be
the result from positive charge leakages of mutated NaV1.5
channels that could lead to a Na+ leak into cardiac myocytes
[27, 28].
Results from segregation analysis indicated that both
variants in the SCN5A gene were most possibly inherited in
a compound heterozygous manner. Heterozygous c.101G>A
was present in family members III-2 (index) and II-2 but
was absent in family members I-2 and III-3. Likewise,
heterozygous c.3832G>A was present in family members III-
2 (index) and III-3 but was absent in family members I-2
and II-2 while only III-2 was the heart block affected family






















































































































































































































































































































































































































gene were autosomal dominant, however, variants that were
inherited in compound heterozygous individuals, similar to
the current case finding, have been previously reported.
For instance, Bezzina et al. described compound het-
erozygous inheritance of 2 variants in the SCN5A gene which
was associated with severe cardiac conduction disturbances
and degenerative changes in the conduction system [36].
A nonsense p.W156X, which is located in the S1-S2 linker
of domain I, was inherited from the father and a missense
p.R225W, which was located in S4 segment of domain I, was
inherited from the mother [36].
Benson et al. studied compound heterozygous variants in
SCN5A in three families with congenital sick sinus syndrome
[13]. A heterozygous missense p. P1298L, which is located in
S4 segment of domain III, and p.G1408R, which is located in
S5-S6 linker of domain III, were found in three siblings of
the first family. Heterozygousmissense p.T220I and p.R1623X
were found in an individual of the second family. These
two variants were located in the S4 segment of domain I
and S4 segment of domain IV. The third family presented
heterozygous deletions p.delF1617 in S3-S4 linker of domain
IV and the missense p.R1632H in S4 segment of domain IV
[13].
Beside the variants in SCN5A gene, 4 heterozygous
missense variants inTTN,NPHP3,DNAI1, andMUC5B genes
were found in the present case. All variants were found in
only the index case, family member III-2. Among these 4
genes, TTN was the most likely cardiac disease associated
gene while lack of evidence for NPHP3, DNAI1, andMUC5B
genes existed. Mutations in TTN have been reported in about
18% of sporadic dilated cardiomyopathies and 25% of familial
autosomal dominant cardiomyopathies and rarely caused
hypertrophic cardiomyopathies [37].
Since this study only focused on the coding variants
in the exon by whole sequencing, noncoding variants and
structural variants were not explored. Moreover, it should
be noted that novel variants in the study were found by
the bioinformatics process so determination of biological
functions will be needed in further studies.
5. Conclusion
In conclusion, this study demonstrated the potential of whole
exome sequencing and a bioinformatics pipeline to identify
the possible causative variants of complete heart block in a
Thai family.The investigation found compound heterozygous
variants in the SCN5A, cardiac sodium channel subunit gene,
of which one was a novel variant and another one was
a known pathogenic variant. Additionally, a heterozygous
missense variant in the TTN, titin or connectin gene, has also
been identified.
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